Cue Biopharma, Inc. (CUE) financial statements (2020 and earlier)

Company profile

Business Address 21 ERIE STREET
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:3139
Cash and cash equivalents3121
Short-term investments 18
Other undisclosed cash, cash equivalents, and short-term investments 0
Restricted cash and investments 0
Receivables1 
Other undisclosed current assets11
Total current assets:3341
Noncurrent Assets
Operating lease, right-of-use asset7
Property, plant and equipment23
Deposits noncurrent assets31
Restricted cash and investments00
Other noncurrent assets11
Total noncurrent assets:125
TOTAL ASSETS:4545
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities34
Accounts payable12
Accrued liabilities22
Debt4 
Deferred rent credit 0
Other undisclosed current liabilities32
Total current liabilities:106
Noncurrent Liabilities
Long-term debt and lease obligation3 
Operating lease, liability3
Other undisclosed noncurrent liabilities55
Total noncurrent liabilities:85
Total liabilities:1811
Stockholders' equity
Stockholders' equity attributable to parent2734
Common stock00
Additional paid in capital127106
Accumulated other comprehensive loss (0)
Accumulated deficit(100)(72)
Total stockholders' equity:2734
TOTAL LIABILITIES AND EQUITY:4545

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
Gross profit:31
Operating expenses(41)(40)
Operating loss:(39)(39)
Nonoperating income11
Other nonoperating income00
Loss from continuing operations before income taxes:(38)(38)
Income tax expense(0)(1)
Other undisclosed loss from continuing operations(1) 
Net loss available to common stockholders, diluted:(39)(39)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
Net loss:(39)(39)
Other comprehensive income0 
Comprehensive loss:(39)(39)
Other undisclosed comprehensive loss, net of tax, attributable to parent(0)(0)
Comprehensive loss, net of tax, attributable to parent:(39)(39)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: